beta

CBAY

CymaBay Therapeutics, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Market Cap: 266 Million

Primary Exchange: NASDAQ

Website: http://www.cymabay.com

Shares Outstanding: 68.9 Million

Float: 66.2 Million

Dividend: (%)

Beta: 0.581834123270478

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 752 trading days

From: 2015-02-18 To: 2018-02-12

Lowest Point:

SYBX, MAT among premarket gainers

via: SeekingAlpha at 2019-06-12 05:16:31:000

Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...

SYBX, MAT among premarket gainers

via: SeekingAlpha at 2019-06-12 05:16:31:000

Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...

CymaBay +4.8% as Raymond James fades 45% sell-off

via: SeekingAlpha at 2019-06-11 13:32:35:000

Raymond James has upgraded CymaBay Therapeutics (NASDAQ: CBAY ) to Strong Buy after today's harsh market reaction to experimental data released this morning. More news on: CymaBay Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...

CymaBay down 40% premarket on disappointing data on NASH candidate seladelpar

via: SeekingAlpha at 2019-06-11 03:29:58:000

CymaBay Therapeutics (NASDAQ: CBAY ) craters 40% premarket on light volume (so far) in reaction to 12-week data from a Phase 2b clinical trial evaluating seladelpar in patients with nonalcoholic steatohepatitis (NASH). More news on: CymaBay Therapeutics, Inc., Healthcare st… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud